ClinConnect ClinConnect Logo
Search / Trial NCT03663348

Registry of Patients With Takotsubo Syndrome

Launched by NYU LANGONE HEALTH · Sep 6, 2018

Trial Information

Current as of July 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying Takotsubo syndrome, often called "broken heart syndrome." This condition can cause heart problems that look similar to a heart attack, but it is usually triggered by extreme emotional or physical stress. The researchers want to learn more about how this syndrome works and how it affects patients over time. They are gathering information from a wide range of patients diagnosed with Takotsubo syndrome to help plan future studies and improve understanding of this condition.

To participate in this study, you need to be at least 18 years old and have been diagnosed with Takotsubo syndrome by a doctor. Unfortunately, if you are unable to give consent for your participation, you wouldn’t be eligible. If you join the study, you can expect to be followed over time to assess your health and quality of life, as well as any stressful events you may experience. This research aims to enhance our knowledge of the syndrome and help improve treatment options for patients like you in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Physician diagnosis of takotsubo syndrome
  • Age\>18 years
  • Exclusion Criteria:
  • - Lack of capacity to provide informed consent

About Nyu Langone Health

NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.

Locations

New York, New York, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials